References:
1. Chugh SS, Havmoeller R, Narayanan K et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47.
2. Blum S, Meyre P, Aeschbacher S et al. Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis. Heart Rhythm 2019;16:502-510.
3. Conen D, Chae CU, Glynn RJ et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011;305:2080-2087.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
5. Kirchhof P, Camm AJ, Goette A et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine 2020;383:1305-1316.
6. Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
7. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011;58:2225-32.
8. Lau DH, Linz D, Schotten U, Mahajan R, Sanders P, Kalman JM. Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis. Heart Lung Circ 2017;26:887-893.
9. Calkins H, Hindricks G, Cappato R et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017;14:e275-e444.
10. Kanagaratnam L, Tomassoni G, Schweikert R et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing and clinical electrophysiology : PACE 2001;24:1774-9.
11. Pappone C, Rosanio S, Oreto G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
12. Tada H, Oral H, Wasmer K et al. Pulmonary vein isolation: comparison of bipolar and unipolar electrograms at successful and unsuccessful ostial ablation sites. Journal of cardiovascular electrophysiology 2002;13:13-9.
13. Proietti R, Santangeli P, Di Biase L et al. Comparative effectiveness of wide antral versus ostial pulmonary vein isolation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2014;7:39-45.
14. Medi C, Sparks PB, Morton JB et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2011;22:137-41.
15. Nilsson B, Chen X, Pehrson S, Køber L, Hilden J, Svendsen JH. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy. Am Heart J 2006;152:537.e1-8.
16. Mohanty S, Mohanty P, Di Biase L et al. Long-term follow-up of patients with paroxysmal atrial fibrillation and severe left atrial scarring: comparison between pulmonary vein antrum isolation only or pulmonary vein isolation combined with either scar homogenization or trigger ablation. Europace 2017;19:1790-1797.
17. Zhao Y, Di Biase L, Trivedi C et al. Importance of non–pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm 2016;13:141-149.
18. Santangeli P, Zado ES, Hutchinson MD et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm 2016;13:374-82.
19. Gökoğlan Y, Mohanty S, Güneş MF et al. Pulmonary Vein Antrum Isolation in Patients With Paroxysmal Atrial Fibrillation: More Than a Decade of Follow-Up. Circ Arrhythm Electrophysiol 2016;9.
20. Mohanty S, Trivedi C, Horton P et al. Natural History of Arrhythmia After Successful Isolation of Pulmonary Veins, Left Atrial Posterior Wall, and Superior Vena Cava in Patients With Paroxysmal Atrial Fibrillation: A Multi-Center Experience. J Am Heart Assoc 2021;10:e020563.
21. Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-53.
22. Verma A, Mantovan R, Macle L et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J 2010;31:1344-56.
23. Hayward RM, Upadhyay GA, Mela T et al. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm 2011;8:994-1000.
24. Dixit S, Marchlinski FE, Lin D et al. Randomized Ablation Strategies for the Treatment of Persistent Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology 2012;5:287-294.
25. Verma A, Jiang C-y, Betts TR et al. Approaches to Catheter Ablation for Persistent Atrial Fibrillation. New England Journal of Medicine 2015;372:1812-1822.
26. Sau A, Al-Aidarous S, Howard J et al. Optimum lesion set and predictors of outcome in persistent atrial fibrillation ablation: a meta-regression analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2019;21:1176-1184.
27. Chen YH, Lin H, Wang Q, Hou JW, Li YG. Efficacy and Safety of Adjunctive Substrate Modification During Pulmonary Vein Isolation for Atrial Fibrillation: A Meta-Analysis. Heart, lung & circulation 2020;29:422-436.
28. Nakai K, Kashiwa A, Kunitomi A, Matsuoka S. Conduction gap mapping of linear ablation lesions with high density mapping. Journal of cardiovascular electrophysiology 2020.
29. Yao Y, Hu F, Du Z et al. The value of extensive catheter linear ablation on persistent atrial fibrillation (the CLEAR-AF Study). Int J Cardiol 2020;316:125-129.
30. Inoue K, Hikoso S, Masuda M et al. Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial. Europace 2021;23:565-574.
31. Gillis K, O’Neill L, Wielandts J-Y et al. Vein of Marshall Ethanol Infusion as First Step for Mitral Isthmus Linear Ablation. JACC: Clinical Electrophysiology 2022;8:367-376.
32. Nakashima T, Pambrun T, Vlachos K et al. Strategy for repeat procedures in patients with persistent atrial fibrillation: Systematic linear ablation with adjunctive ethanol infusion into the vein of Marshall versus electrophysiology-guided ablation. J Cardiovasc Electrophysiol 2022.
33. Lai Y, Liu X, Sang C et al. Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the ”upgraded 2C3L” approach) for catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2021;32:1849-1856.
34. Pontoppidan J, Nielsen JC, Poulsen SH et al. Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial. Heart 2009;95:994-9.
35. Mesquita J, Ferreira AM, Cavaco D et al. Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure. Int J Cardiol 2018;259:82-87.
36. Kim SH, Oh YS, Choi Y et al. Long-Term Efficacy of Prophylactic Cavotricuspid Isthmus Ablation during Atrial Fibrillation Ablation in Patients Without Typical Atrial Flutter: a Prospective, Multicentre, Randomized Trial. Korean Circ J 2021;51:58-64.
37. Romero J, Patel K, Briceno D et al. Cavotricuspid isthmus line in patients undergoing catheter ablation of atrial fibrillation with or without history of typical atrial flutter: A meta-analysis. J Cardiovasc Electrophysiol 2020;31:1987-1995.
38. Gucuk Ipek E, Marine J, Yang E et al. Predictors and Incidence of Atrial Flutter After Catheter Ablation of Atrial Fibrillation. The American journal of cardiology 2019;124:1690-1696.
39. Krummen DE, Swarup V, Narayan SM. The role of rotors in atrial fibrillation. J Thorac Dis 2015;7:142-151.
40. Davidenko JM, Kent PF, Chialvo DR, Michaels DC, Jalife J. Sustained vortex-like waves in normal isolated ventricular muscle. Proceedings of the National Academy of Sciences of the United States of America 1990;87:8785-9.
41. Narayan SM, Shivkumar K, Krummen DE, Miller JM, Rappel WJ. Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms. Circulation Arrhythmia and electrophysiology 2013;6:58-67.
42. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012;60:628-36.
43. Peigh G, Wasserlauf J, Kaplan RM et al. Repeat pulmonary vein isolation with or without FIRM-guided ablation for recurrent atrial fibrillation with pulmonary vein reconnection. Journal of cardiovascular electrophysiology 2020;31:1031-1037.
44. Tilz R, Lenz CL, Sommer PS et al. P2846Focal impulse and rotor modulation ablation versus pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation (FIRMAP AF study). European Heart Journal 2019;40.
45. Mohanty S, Mohanty P, Trivedi C et al. Long-Term Outcome of Pulmonary Vein Isolation With and Without Focal Impulse and Rotor Modulation Mapping. Circulation: Arrhythmia and Electrophysiology 2018;11:e005789.
46. Liu PR, Friedman DJ, Barnett AS, Jackson KP, Daubert JP, Piccini JP. Focal impulse and rotor modulation of atrial rotors during atrial fibrillation leads to organization of left atrial activation as reflected by waveform morphology recurrence quantification analysis and organizational index. Journal of arrhythmia 2020;36:311-318.
47. Romero J, Gabr M, Alviz I et al. Focal impulse and rotor modulation guided ablation versus pulmonary vein isolation for atrial fibrillation: A meta-analysis of head-to-head comparative studies. Journal of Cardiovascular Electrophysiology 2021;32:1822-1832.
48. Blandino A, Bianchi F, Grossi S et al. Left Atrial Substrate Modification Targeting Low-Voltage Areas for Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Pacing Clin Electrophysiol 2017;40:199-212.
49. Bisbal F, Benito E, Teis A et al. Magnetic Resonance Imaging-Guided Fibrosis Ablation for the Treatment of Atrial Fibrillation: The ALICIA Trial. Circulation: Arrhythmia and Electrophysiology;0.
50. Dean NFMTGJM. Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation:The DECAAF II trial. in press 2021.
51. Yamaguchi T, Tsuchiya T, Nakahara S et al. Efficacy of Left Atrial Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol 2016;27:1055-63.
52. Kottkamp H, Berg J, Bender R, Rieger A, Schreiber D. Box Isolation of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation. J Cardiovasc Electrophysiol 2016;27:22-30.
53. Abdulla R, Blew GA, Holterman MJ. Cardiovascular embryology. Pediatr Cardiol 2004;25:191-200.
54. Suenari K, Chen YC, Kao YH et al. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Basic Res Cardiol 2011;106:65-74.
55. Hunter RJ, Liu Y, Lu Y, Wang W, Schilling RJ. Left Atrial Wall Stress Distribution and Its Relationship to Electrophysiologic Remodeling in Persistent Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology 2012;5:351-360.
56. Katritsis DG, Pokushalov E, Romanov A et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol 2013;62:2318-25.
57. Driessen AHG, Berger WR, Krul SPJ et al. Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study. J Am Coll Cardiol 2016;68:1155-1165.
58. Kampaktsis PN, Oikonomou EK, D YC, Cheung JW. Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials. J Interv Card Electrophysiol 2017;50:253-260.
59. Lim HS, Hocini M, Dubois R et al. Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation. Journal of the American College of Cardiology 2017;69:1257-1269.
60. Bai R, Di Biase L, Mohanty P et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm 2016;13:132-40.
61. DeLurgio DB, Crossen KJ, Gill J et al. Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology 2020;13:e009288.
62. Ahn J, Shin DG, Han SJ, Lim HE. Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial. Europace 2022.
63. Aryana A, Allen SL, Pujara DK et al. Concomitant Pulmonary Vein and Posterior Wall Isolation Using Cryoballoon With Adjunct Radiofrequency in Persistent Atrial Fibrillation. JACC Clin Electrophysiol 2021;7:187-196.
64. Mun H-S, Joung B, Shim J et al. Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study. Heart (British Cardiac Society) 2012;98:480-484.
65. Tamborero D, Mont L, Berruezo A et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol 2009;2:35-40.
66. Lee JM, Shim J, Park J et al. The Electrical Isolation of the Left Atrial Posterior Wall in Catheter Ablation of Persistent Atrial Fibrillation. J Am Coll Cardiol EP 2019;5:1253-1261.
67. Pak H-N, Park J, Park J-W et al. Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multi-center, Prospective, Randomized Study (PEACEFUL). Circulation: Arrhythmia and Electrophysiology;0.
68. Romero J, Polanco D, Alviz I et al. Posterior Wall Electrical Isolation in Patients Undergoing Catheter Ablation for Paroxysmal and Non-Paroxysmal Atrial Fibrillation:A Meta-Analysis of Randomized Controlled Trial. Journal of American College of Cardiology EP 2021;in press.
69. Hong KL, Baley J, Baranchuk A, Bisleri G, Glover BM. Epicardial Electrical Activation During Atrial Fibrillation. Looking at the Other Side of the Coin 2019;1:401-402.
70. Groot Nd, Does Lvd, Yaksh A et al. Direct Proof of Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation in Humans. Circulation: Arrhythmia and Electrophysiology 2016;9:e003648.
71. Markman TM, Hyman MC, Kumareswaran R et al. Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation. Heart rhythm : the official journal of the Heart Rhythm Society 2020.
72. Schmidt M, Nölker G, Marschang H et al. Incidence of oesophageal wall injury post-pulmonary vein antrum isolation for treatment of patients with atrial fibrillation. Europace 2008;10:205-9.
73. Barbhaiya CR, Kumar S, John RM et al. Global survey of esophageal and gastric injury in atrial fibrillation ablation: incidence, time to presentation, and outcomes. J Am Coll Cardiol 2015;65:1377-1378.
74. Kiuchi K, Okajima K, Shimane A et al. Impact of esophageal temperature monitoring guided atrial fibrillation ablation on preventing asymptomatic excessive transmural injury. Journal of arrhythmia 2016;32:36-41.
75. Singh SM, d’Avila A, Doshi SK et al. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circulation Arrhythmia and electrophysiology 2008;1:162-8.
76. Zhang X, Kuang X, Gao X et al. RESCUE-AF in Patients Undergoing Atrial Fibrillation Ablation. Circulation: Arrhythmia and Electrophysiology 2019;12:e007044.
77. Verma A, Kilicaslan F, Adams JR et al. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis. J Cardiovasc Electrophysiol 2006;17:741-6.
78. Kim JS, Shin SY, Na JO et al. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation?: A prospective randomized clinical trial. Int J Cardiol 2015;181:277-83.
79. Tsai CF, Tai CT, Hsieh MH et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation 2000;102:67-74.
80. Lin WS, Tai CT, Hsieh MH et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003;107:3176-83.
81. Gianni C, Sanchez JE, Mohanty S et al. Isolation of the superior vena cava from the right atrial posterior wall: a novel ablation approach. Europace 2018;20:e124-e132.
82. Overeinder I, Osório TG, Călburean PA et al. Comparison between superior vena cava ablation in addition to pulmonary vein isolation and standard pulmonary vein isolation in patients with paroxysmal atrial fibrillation with the cryoballoon technique. J Interv Card Electrophysiol 2021;62:579-586.
83. Corrado A, Bonso A, Madalosso M et al. Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study. J Cardiovasc Electrophysiol 2010;21:1-5.
84. Sharma SP, Sangha RS, Dahal K, Krishnamoorthy P. The role of empiric superior vena cava isolation in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol 2017;48:61-67.
85. Yoshiga Y, Shimizu A, Ueyama T et al. Strict sequential catheter ablation strategy targeting the pulmonary veins and superior vena cava for persistent atrial fibrillation. J Cardiol 2018;72:128-134.
86. Della Rocca DG, Mohanty S, Mohanty P et al. Long-term outcomes of catheter ablation in patients with longstanding persistent atrial fibrillation lasting less than 2 years. J Cardiovasc Electrophysiol 2018;29:1607-1615.
87. Oral H, Ozaydin M, Chugh A et al. Role of the coronary sinus in maintenance of atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:1329-36.
88. Haïssaguerre M, Hocini M, Takahashi Y et al. Impact of catheter ablation of the coronary sinus on paroxysmal or persistent atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:378-86.
89. Knecht S, O’Neill MD, Matsuo S et al. Focal arrhythmia confined within the coronary sinus and maintaining atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:1140-6.
90. Chang HY, Lo LW, Lin YJ et al. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy. J Cardiovasc Electrophysiol 2013;24:250-8.
91. Morita H, Zipes DP, Morita ST, Wu J. Isolation of canine coronary sinus musculature from the atria by radiofrequency catheter ablation prevents induction of atrial fibrillation. Circ Arrhythm Electrophysiol 2014;7:1181-8.
92. Della Rocca DG, Di Biase L, Mohanty S et al. ELECTRICAL ISOLATION VERSUS FOCAL ABLATION OF THE CORONARY SINUS IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION. Journal of the American College of Cardiology 2020;75:281.
93. Kuo L, Frankel DS, Lin A et al. PRECAF Randomized Controlled Trial. Circ Arrhythm Electrophysiol 2021;14:e008993.
94. Güneş MF, Gökoğlan Y, L DIB et al. Ablating the Posterior Heart: Cardioesophageal Fistula Complicating Radiofrequency Ablation in the Coronary Sinus. J Cardiovasc Electrophysiol 2015;26:1376-8.
95. Di Biase L, Burkhardt JD, Mohanty P et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010;122:109-18.
96. Di Biase L, Burkhardt JD, Mohanty P et al. Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial. J Am Coll Cardiol 2016;68:1929-1940.
97. Romero J, Gabr M, Patel K et al. Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis. EP Europace 2020;23:226-237.
98. Friedman DJ, Black-Maier EW, Barnett AS et al. Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis. J Am Coll Cardiol EP 2018;4:112-120.
99. Romero J, Di Biase L, Mohanty S et al. Long-Term Outcomes of Left Atrial Appendage Electrical Isolation in Patients With Nonparoxysmal Atrial Fibrillation: A Propensity Score-Matched Analysis. Circ Arrhythm Electrophysiol 2020;13:e008390.
100. Yorgun H, Canpolat U, Kocyigit D, Çöteli C, Evranos B, Aytemir K. Left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation: one-year clinical outcome after cryoballoon-based ablation. Europace 2017;19:758-768.
101. Romero J, Natale A, Cerna L et al. Imaging Integration to Localize and Protect the Left Coronary Artery in Patients Undergoing LAAEI. JACC: Clinical Electrophysiology 2020;6:157-167.
102. Romero J, Tarantino N, Cerrud-Rodriguez R, Alviz I, Grupposso V, Di Biase L. Segmental left atrial appendage electrical isolation to avoid left phrenic nerve damage. HeartRhythm Case Rep 2019;5:269-273.
103. Rillig A, Tilz RR, Lin T et al. Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias. Circ Arrhythm Electrophysiol 2016;9:e003461.
104. Di Biase L, Mohanty S, Trivedi C et al. Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage. J Am Coll Cardiol 2019;74:1019-1028.
105. Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.
106. Chatterjee S, Herrmann HC, Wilensky RL et al. Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database. JAMA Internal Medicine 2015;175:1104-1109.
107. Bartus K, Han FT, Bednarek J et al. Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation. Initial Clinical Experience 2013;62:108-118.
108. Lakkireddy D, Afzal MR, Lee RJ et al. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation. Heart Rhythm 2016;13:1030-1036.
109. David J Wilber M, Dhanunjaya Lakkireddy M, FHRS. Outcomes of Adjunctive LAA Utilizing LARIAT Compared to Pulmonary Vein Atrial Isolation Alone. in press.
110. Dearstine M, Taylor W, Kerut EK. Persistent left superior vena cava: chest x-ray and echocardiographic findings. Echocardiography 2000;17:453-5.
111. Kim YG, Han S, Choi J-I et al. Impact of persistent left superior vena cava on radiofrequency catheter ablation in patients with atrial fibrillation. EP Europace 2019;21:1824-1832.
112. Santoro F, Rillig A, Sohns C et al. Second-Generation Cryoballoon Atrial Fibrillation Ablation in Patients With Persistent Left Superior Caval Vein. JACC Clin Electrophysiol 2019;5:590-598.
113. Fujino T, Yuzawa H, Kinoshita T, Shinohara M, Okishige K, Ikeda T. A case of successful cryoballoon ablation of paroxysmal atrial fibrillation originating from a persistent left superior vena cava. J Cardiol Cases 2019;20:77-80.
114. Briceño DF, Valderrábano M. Recurrent perimitral flutter due to vein of Marshall epicardial connections bypassing the mitral isthmus: response to ethanol infusion. Circulation Arrhythmia and electrophysiology 2014;7:988-989.
115. Kurotobi T, Ito H, Inoue K et al. Marshall vein as arrhythmogenic source in patients with atrial fibrillation: correlation between its anatomy and electrophysiological findings. J Cardiovasc Electrophysiol 2006;17:1062-7.
116. Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation. Heart rhythm 2016;13:593-601.
117. Chugh A, Gurm HS, Krishnasamy K et al. Spectrum of atrial arrhythmias using the ligament of Marshall in patients with atrial fibrillation. Heart Rhythm 2018;15:17-24.
118. Valderrábano M, Peterson LE, Swarup V et al. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA 2020;324:1620-1628.
119. Lador A, Valderrabano M. B-PO05-066 VEIN OF MARSHALL ALCOHOL IN REPEAT ABLATION OF PERSISTENT ATRIAL FIBRILLATION (MARS-AF). Heart Rhythm 2021;18:S398.
120. Steinberg JS, Shabanov V, Ponomarev D et al. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial. Jama 2020;323:248-255.
121. Ukena C, Becker N, Pavlicek V et al. Catheter-based renal denervation as adjunct to pulmonary vein isolation for treatment of atrial fibrillation: a systematic review and meta-analysis. J Hypertens 2020;38:783-790.
122. Kewcharoen J, Vutthikraivit W, Rattanawong P et al. Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials. Journal of Interventional Cardiac Electrophysiology 2020.
123. Kitamura T, Takigawa M, Derval N et al. Atrial tachycardia circuits include low voltage area from index atrial fibrillation ablation relationship between RF ablation lesion and AT. Journal of Cardiovascular Electrophysiology 2020;31:1640-1648.
124. Clarnette JA, Brooks AG, Mahajan R et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018;20:f366-f376.
125. Fiala M, Chovančík J, Nevřalová R et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 2008;22:13-21.
126. Liu X, Long D, Dong J et al. Is Circumferential Pulmonary Vein Isolation Preferable to Stepwise Segmental Pulmonary Vein Isolation for Patients With Paroxysmal Atrial Fibrillation?
A Randomized Study. Circulation Journal 2006;70:1392-1397.
127. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355-60.
128. Arentz T, Weber R, Bürkle G et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 2007;115:3057-63.
129. Jin Hwang H, Myung Lee J, Joung B et al. Atrial electroanatomical remodeling as a determinant of different outcomes between two current ablation strategies: circumferential pulmonary vein isolation vs pulmonary vein isolation. Clin Cardiol 2010;33:E69-74.
130. Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:532-7.
131. CHEN M, YANG B, CHEN H et al. Randomized Comparison Between Pulmonary Vein Antral Isolation versus Complex Fractionated Electrogram Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 2011;22:973-981.
132. DEISENHOFER I, ESTNER H, REENTS T et al. Does Electrogram Guided Substrate Ablation Add to the Success of Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation? A Prospective, Randomized Study. Journal of Cardiovascular Electrophysiology 2009;20:514-521.
133. Di Biase L, Elayi CS, Fahmy TS et al. Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiol 2009;2:113-9.
134. Nührich JM, Steven D, Berner I et al. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study. Heart Rhythm 2014;11:1536-42.
135. Verma A, Patel D, Famy T et al. Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:151-6.
136. Fadahunsi O, Talabi T, Olowoyeye A, Iluyomade A, Shogbesan O, Donato A. Ablation of Complex Fractionated Atrial Electrograms for Atrial Fibrillation Rhythm Control: A Systematic Review and Meta-analysis. Can J Cardiol 2016;32:791-802.
137. Verma A, Novak P, Macle L et al. A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy. Heart Rhythm 2008;5:198-205.
138. Vogler J, Willems S, Sultan A et al. Pulmonary Vein Isolation Versus Defragmentation: The CHASE-AF Clinical Trial. J Am Coll Cardiol 2015;66:2743-2752.
139. Oral H, Chugh A, Yoshida K et al. A Randomized Assessment of the Incremental Role of Ablation of Complex Fractionated Atrial Electrograms After Antral Pulmonary Vein Isolation for Long-Lasting Persistent Atrial Fibrillation. Journal of the American College of Cardiology 2009;53:782-789.
140. Wong KC, Paisey JR, Sopher M et al. No Benefit of Complex Fractionated Atrial Electrogram Ablation in Addition to Circumferential Pulmonary Vein Ablation and Linear Ablation: Benefit of Complex Ablation Study. Circulation Arrhythmia and electrophysiology 2015;8:1316-24.
141. Elayi CS, Verma A, Di Biase L et al. Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies. Heart Rhythm 2008;5:1658-1664.
142. LIN Y-J, TAI C-T, CHANG S-L et al. Efficacy of Additional Ablation of Complex Fractionated Atrial Electrograms for Catheter Ablation of Nonparoxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 2009;20:607-615.
143. Dixit S, Marchlinski FE, Lin D et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol 2012;5:287-94.
144. Sawhney N, Anousheh R, Chen W, Feld GK. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circulation Arrhythmia and electrophysiology 2010;3:243-8.
145. Wynn GJ, Panikker S, Morgan M et al. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm 2016;13:399-406.
146. Gaita F, Caponi D, Scaglione M et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008;1:269-75.
147. FASSINI G, RIVA S, CHIODELLI R et al. Left Mitral Isthmus Ablation Associated with PV Isolation: Long-Term Results of a Prospective Randomized Study. Journal of Cardiovascular Electrophysiology 2005;16:1150-1156.
148. Willems S, Klemm H, Rostock T et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J 2006;27:2871-8.
149. Wazni O, Marrouche NF, Martin DO et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 2003;108:2479-83.
150. Lee WC, Fang HY, Chen HC et al. Additional cavotricuspid isthmus block ablation may not improve the outcome of atrial fibrillation ablation. Pacing Clin Electrophysiol 2019;42:1421-1428.
151. WANG Y-L, LIU X, TAN H-W et al. Evaluation of Linear Lesions in the Left and Right Atrium in Ablation of Long-standing Atrial Fibrillation. Pacing and Clinical Electrophysiology 2013;36:1202-1210.
152. Mohanty S, Gianni C, Trivedi C et al. Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up. Am Heart J 2018;205:145-148.
153. Brachmann J, Hummel JD, Wilber DJ et al. Prospective randomized comparison of rotor ablation vs conventional ablation for treatment of persistent atrial fibrillation—The REAFFIRM trial. Heart Rhythm 2019;16:963-965.
154. Peigh G, Wasserlauf J, Kaplan RM et al. Abstract 15877: Focal Impulse Rotor Modulation Guided Ablation versus Isolated Repeat Pulmonary Vein Isolation of Non-Paroxysmal Atrial Fibrillation After Failed Pulmonary Vein Isolation: A Case Control Study. Circulation 2019;140:A15877-A15877.
155. Kirzner JM, Raelson CA, Liu CF et al. Effects of focal impulse and rotor modulation-guided ablation on atrial arrhythmia termination and inducibility: Impact on outcomes after treatment of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2019;30:2773-2781.
156. Rolf S, Kircher S, Arya A et al. Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology 2014;7:825-833.
157. Jadidi AS, Lehrmann H, Keyl C et al. Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics. Circulation: Arrhythmia and Electrophysiology 2016;9:e002962.
158. Mikhaylov E, Kanidieva A, Sviridova N et al. Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation: a 3-year follow-up study. Europace 2011;13:362-70.
159. Kim T-H, Park J, Park J-K et al. Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized study. EP Europace 2014;17:388-395.
160. Lim TW, Koay CH, See VA et al. Single-Ring Posterior Left Atrial (Box) Isolation Results in a Different Mode of Recurrence Compared With Wide Antral Pulmonary Vein Isolation on Long-Term Follow-Up. Circulation: Arrhythmia and Electrophysiology 2012;5:968-977.
161. Sutter JS, Lokhnygina Y, Daubert JP et al. Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation. Am Heart J 2020;220:89-96.
162. Aryana A, Baker JH, Espinosa Ginic MA et al. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience. Heart Rhythm 2018;15:1121-1129.
163. Wang XH, Liu X, Sun YM, Shi HF, Zhou L, Gu JN. Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study. Europace 2008;10:600-5.
164. Da Costa A, Levallois M, Romeyer-Bouchard C, Bisch L, Gate-Martinet A, Isaaz K. Remote-controlled magnetic pulmonary vein isolation combined with superior vena cava isolation for paroxysmal atrial fibrillation: a prospective randomized study. Arch Cardiovasc Dis 2015;108:163-71.
165. Heeger CH, Rillig A, Geisler D et al. Left Atrial Appendage Isolation in Patients Not Responding to Pulmonary Vein Isolation. Circulation 2019;139:712-715.
166. Panikker S, Jarman JW, Virmani R et al. Left Atrial Appendage Electrical Isolation and Concomitant Device Occlusion to Treat Persistent Atrial Fibrillation: A First-in-Human Safety, Feasibility, and Efficacy Study. Circulation Arrhythmia and electrophysiology 2016;9.